Lab Med Online.  2015 Oct;5(4):219-222. 10.3343/lmo.2015.5.4.219.

A Case of Ceftazidime-Nonsusceptible Burkholderia pseudomallei Infection

Affiliations
  • 1Department of Laboratory Medicine, School of Medicine, Kyung Hee University, Seoul, Korea. leehejo@khmc.or.kr
  • 2Department of Laboratory Medicine, Kyung Hee University Hospital, Seoul, Korea.
  • 3Department of Internal Medicine, School of Medicine, Kyung Hee University, Seoul, Korea.

Abstract

Melioidosis, which is an infectious disease caused by Burkholderia pseudomallei, is prevalent mostly in Southeast Asia and northern Australia; it can progress to abscess formation, pneumonia and sepsis, and ultimately cause death. A 66-yr-old male patient with diabetes mellitus was hospitalized for sepsis 3 months after coming back from Cambodia, and B. pseudomallei was identified from the blood culture. The B. pseudomallei strain was found to be susceptible to carbapenem, and non-susceptible to trimethoprim/sulfamethoxazole and ceftazidime. Although the patient was treated with carbapenem, to which the strain was susceptible, the bacteremia persisted, and progressed to septic shock and pneumonia, and eventually to acute respiratory distress syndrome (ARDS). The patient died on the 12th day of hospitalization. This study, which reports the first case of ceftazidime-nonsusceptible B. pseudomallei in Korea, indicates the importance of B. pseudomallei infection, which is highly likely to be imported to Korea, and discuss its clinical progress, which can lead to fatality.

Keyword

Burkholderia pseudomallei; Ceftazidime non-susceptible; Melioidosis
Full Text Links
  • LMO
Share
  • Twitter
  • Facebook
Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr